IBDEI1WK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33815,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,33815,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,33816,0)
 ;;=L40.1^^191^1976^21
 ;;^UTILITY(U,$J,358.3,33816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33816,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,33816,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,33816,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,33817,0)
 ;;=L40.9^^191^1976^19
 ;;^UTILITY(U,$J,358.3,33817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33817,1,3,0)
 ;;=3^Psoriasis, unspec
 ;;^UTILITY(U,$J,358.3,33817,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,33817,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,33818,0)
 ;;=L40.3^^191^1976^22
 ;;^UTILITY(U,$J,358.3,33818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33818,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,33818,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,33818,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,33819,0)
 ;;=L40.8^^191^1976^17
 ;;^UTILITY(U,$J,358.3,33819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33819,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,33819,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,33819,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,33820,0)
 ;;=L40.4^^191^1976^20
 ;;^UTILITY(U,$J,358.3,33820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33820,1,3,0)
 ;;=3^Psoriasis,Guttate
 ;;^UTILITY(U,$J,358.3,33820,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,33820,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,33821,0)
 ;;=M72.2^^191^1976^10
 ;;^UTILITY(U,$J,358.3,33821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33821,1,3,0)
 ;;=3^Plantar fascial fibromatosis
 ;;^UTILITY(U,$J,358.3,33821,1,4,0)
 ;;=4^M72.2
 ;;^UTILITY(U,$J,358.3,33821,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,33822,0)
 ;;=M72.2^^191^1976^11
 ;;^UTILITY(U,$J,358.3,33822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33822,1,3,0)
 ;;=3^Plantar fascial fibromatosis
 ;;^UTILITY(U,$J,358.3,33822,1,4,0)
 ;;=4^M72.2
 ;;^UTILITY(U,$J,358.3,33822,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,33823,0)
 ;;=M15.9^^191^1976^12
 ;;^UTILITY(U,$J,358.3,33823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33823,1,3,0)
 ;;=3^Polyosteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,33823,1,4,0)
 ;;=4^M15.9
 ;;^UTILITY(U,$J,358.3,33823,2)
 ;;=^5010768
 ;;^UTILITY(U,$J,358.3,33824,0)
 ;;=I87.002^^191^1976^15
 ;;^UTILITY(U,$J,358.3,33824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33824,1,3,0)
 ;;=3^Postthrom syndr w/o compl of lft lwr extrem
 ;;^UTILITY(U,$J,358.3,33824,1,4,0)
 ;;=4^I87.002
 ;;^UTILITY(U,$J,358.3,33824,2)
 ;;=^5008028
 ;;^UTILITY(U,$J,358.3,33825,0)
 ;;=I73.9^^191^1976^2
 ;;^UTILITY(U,$J,358.3,33825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33825,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,33825,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,33825,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,33826,0)
 ;;=M06.372^^191^1977^12
 ;;^UTILITY(U,$J,358.3,33826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33826,1,3,0)
 ;;=3^Rheumatoid nodule, left Ankle/Foot
 ;;^UTILITY(U,$J,358.3,33826,1,4,0)
 ;;=4^M06.372
 ;;^UTILITY(U,$J,358.3,33826,2)
 ;;=^5010116
 ;;^UTILITY(U,$J,358.3,33827,0)
 ;;=M06.371^^191^1977^13
 ;;^UTILITY(U,$J,358.3,33827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33827,1,3,0)
 ;;=3^Rheumatoid nodule, right Ankle/Foot
 ;;^UTILITY(U,$J,358.3,33827,1,4,0)
 ;;=4^M06.371
 ;;^UTILITY(U,$J,358.3,33827,2)
 ;;=^5010115
 ;;^UTILITY(U,$J,358.3,33828,0)
 ;;=M05.59^^191^1977^8
 ;;^UTILITY(U,$J,358.3,33828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33828,1,3,0)
 ;;=3^Rheum polyneuropathy w/ rheum arthr mult site
 ;;^UTILITY(U,$J,358.3,33828,1,4,0)
 ;;=4^M05.59
